Venous Insufficiency, Varicose Veins, Obesity
Conditions
Interventions
Experimental group: in patients members 91, elastic sock compression will be oriented in the first 48 hours
and the use of stocking by a further period of 3 weeks after the completion of 1 or 2 sessions with foam sclerotherapy (Polidocanol) via transdermal selected vein puncture with administration of 2 ml
Procedure/surgery
Sponsors
Hospital Universitário da Universidade Federal de Sergipe
Hospital Universitário da Universidade Federal de Sergipe
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Aged between 18 and 60 years inclusive. Male and female sex. Informed consent authorization. Reflux diagnosed by Doppler ultrasound in any saphenous vein extension and / or trunk varicose veins measuring between 4 and 8mm in diameter inclusive. Varicose veins classified APEC 3,4,5 and 6. Body mass index (BMI) between 25 and 40kg/m2.
Exclusion criteria
Exclusion criteria: Patient with psychiatric disorder or limitation in the technique compreendimento. Women during pregnancy or risk pregnancy (without effective contraception) or nursing. Patients with a personal history of deep vein thrombosis and / or PET. Patients with known allergy to Polidocanol (synonyms: Lauromacrogol 400, macrogollauryleter, PEG9lauryl-alcohol). Patients with severe or chronic decompensated (hepatic insufficiency, renal insufficiency, CHF, COPD, respiratory insufficiency, progressive, malignant disease, hypertension and / or diabetes mellitus uncompensated). Intra-atrial or ventricular septal defect diagnosed by echocardiography. Closing of / attend the scheduled follow-ups. Patients who have Peripheral Arterial Disease Installed (ankle-brachial index less than 0, 9)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected primary outcome will be complete luminal occlusion of the vessel underwent embolization with polidocanol and use or non-use of elastic stockings for long periods. The method used to check the expected outcome will be the vascular echo doppler in 3 weeks, 3 months and 6 months after the procedure. The parameter that will be used to check the outcome actually occurred will be the absence of detectable speed through the vascular echo Doppler that show what actually occurred thrombosis within the vessel. | — |
Secondary
| Measure | Time frame |
|---|---|
| The expected secondary outcome will be the presence of local and / or systemic complications of treatment. The method used to check the expected outcome will be the vascular clinical examination carried out in 3 weeks, 3 months and 6 months after the procedure. The parameter used to verify that the outcome actually occurred will be the presence of areas of dermal necrosis, tomboflebite symptomatic deep vein thrombosis, visual disturbances, chest pain, allergic reaction and death. | — |
Countries
Brazil
Contacts
Public ContactMarco Nunes
Universidade Federal de Sergipe
Outcome results
None listed